Related Experiment Video
Updated: Aug 20, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin
Hsin-Yi Chen1, Che-Hung Shen, Yuh-Tyng Tsai
1Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Abstract:
Brk (for breast tumor kinase) is a nonreceptor tyrosine kinase containing SH3, SH2, and tyrosine kinase catalytic domains. Brk was originally identified from a human metastatic breast tumor, and its overexpression is frequently observed in breast cancer and several other cancer types. However, the molecular mechanism by which this kinase participates in tumorigenesis remains poorly characterized. In the present study, we not only identified paxillin as the binding partner and substrate of Brk but also discovered a novel signaling pathway by which Brk mediates epidermal growth factor (EGF)-induced paxillin phosphorylation. We show that EGF stimulation activates the catalytic activity of Brk, which in turn phosphorylates paxillin at Y31 and Y118. These phosphorylation events promote the activation of small GTPase Rac1 via the function of CrkII. Through this pathway, Brk is capable of promoting cell motility and invasion and functions as a mediator of EGF-induced migration and invasion. In accordance with these functional roles, Brk translocates to membrane ruffles, where it colocalizes with paxillin during cell migration. Together, our findings identify novel signaling and biological roles of Brk and indicate the first potential link between Brk and metastatic malignancy.
Insights
Breast tumor kinase (Brk) phosphorylates paxillin, activating Rac1 and promoting cell invasion. This reveals a novel pathway linking Brk to cancer metastasis and EGF-induced migration.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Breast tumor kinase (Brk) is a nonreceptor tyrosine kinase overexpressed in various cancers.
- The precise role of Brk in tumorigenesis is not fully understood.
- Understanding Brk's molecular mechanisms is crucial for cancer research.
Purpose of the Study:
- To elucidate the molecular mechanism of Brk in tumorigenesis.
- To identify Brk's binding partners and substrates.
- To investigate the role of Brk in epidermal growth factor (EGF)-induced cell processes.
Main Methods:
- Protein-protein interaction studies to identify Brk binding partners.
- Kinase assays to determine Brk's substrate specificity.
- Cellular assays to assess the impact of Brk on cell motility and invasion.
Main Results:
- Paxillin was identified as a direct binding partner and substrate of Brk.
- Brk phosphorylates paxillin at specific tyrosine residues (Y31 and Y118) upon EGF stimulation.
- Brk-mediated paxillin phosphorylation activates Rac1 signaling, enhancing cell motility and invasion.
Conclusions:
- Brk acts as a key mediator in EGF-induced cell migration and invasion through paxillin phosphorylation.
- Brk's signaling pathway involving paxillin and Rac1 provides a novel link to cancer metastasis.
- These findings highlight Brk as a potential therapeutic target in metastatic cancers.
Related Concept Videos
Cell Polarization by Rho Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cell Migration
Cell Migration
MAPK Signaling Cascades
Mechanism of Lamellipodia Formation

